TELO vs. ACIU, ALDX, ACRV, TSVT, PBYI, XBIT, NKTR, OVID, QURE, and AEON
Should you be buying Telomir Pharmaceuticals stock or one of its competitors? The main competitors of Telomir Pharmaceuticals include AC Immune (ACIU), Aldeyra Therapeutics (ALDX), Acrivon Therapeutics (ACRV), 2seventy bio (TSVT), Puma Biotechnology (PBYI), XBiotech (XBIT), Nektar Therapeutics (NKTR), Ovid Therapeutics (OVID), uniQure (QURE), and AEON Biopharma (AEON). These companies are all part of the "pharmaceutical preparations" industry.
Telomir Pharmaceuticals (NASDAQ:TELO) and AC Immune (NASDAQ:ACIU) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.
In the previous week, AC Immune had 2 more articles in the media than Telomir Pharmaceuticals. MarketBeat recorded 4 mentions for AC Immune and 2 mentions for Telomir Pharmaceuticals. AC Immune's average media sentiment score of 1.01 beat Telomir Pharmaceuticals' score of 0.00 indicating that AC Immune is being referred to more favorably in the news media.
51.4% of AC Immune shares are held by institutional investors. 4.6% of AC Immune shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Telomir Pharmaceuticals has higher earnings, but lower revenue than AC Immune.
Telomir Pharmaceuticals' return on equity of 0.00% beat AC Immune's return on equity.
AC Immune has a consensus price target of $16.00, suggesting a potential upside of 580.85%. Given AC Immune's higher probable upside, analysts plainly believe AC Immune is more favorable than Telomir Pharmaceuticals.
AC Immune received 253 more outperform votes than Telomir Pharmaceuticals when rated by MarketBeat users.
Summary
AC Immune beats Telomir Pharmaceuticals on 8 of the 11 factors compared between the two stocks.
Get Telomir Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TELO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Telomir Pharmaceuticals Competitors List
Related Companies and Tools
